Multiple gene therapy trials report high remission rates for certain lymphoma patients – Xinhua
WHBL Sheboygan |
Multiple gene therapy trials report high remission rates for certain lymphoma patients
Xinhua WASHINGTON, Dec. 10 (Xinhua) — In three clinical trials conducted in multiple sites, a novel gene therapy that genetically engineers a patient's immune system to attack cancer cells demonstrated long-lasting remissions in certain lymphoma patients … Phase 2 CAR-T study reports significant remission rates at 15-month follow up |
